EVE has to go up 400% to make up for my lost gains on QBL. That...

EVE has to go up 400% to make up for my lost gains on QBL. That was the first medical marijuana stock on the ASX I did research on and I didn't buy any, even though I understood the product and market. Didn't make the same mistake on EVE as this has potential much greater than QBL as they aren't just both medical marijuana, they are completely different fields inside the one.

I'm also buying ACL a shell worth AU$3Mio as that is getting some buying. The board is all medical and the CIGS code is pharmaceutical. I have spoken to the company and tried to introduce a meluka and terpene deal that is medical marijuana involved. It could be something for shareholders of EVE to look at also.